Oscar Health, Inc.
OSCR
$16.80
$1.388.95%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.86B | 3.04B | 2.39B | 2.42B | 2.21B |
| Total Other Revenue | 6.50M | 4.33M | 4.81M | 4.90M | 5.23M |
| Total Revenue | 2.86B | 3.05B | 2.39B | 2.42B | 2.22B |
| Cost of Revenue | 2.55B | 2.26B | 2.07B | 2.00B | 1.71B |
| Gross Profit | 310.97M | 786.61M | 327.32M | 419.50M | 510.62M |
| SG&A Expenses | 534.49M | 482.76M | 465.82M | 460.38M | 435.21M |
| Depreciation & Amortization | 6.97M | 6.73M | 9.23M | 7.50M | 7.60M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.09B | 2.75B | 2.54B | 2.47B | 2.15B |
| Operating Income | -230.48M | 297.12M | -147.73M | -48.37M | 67.81M |
| Income Before Tax | -233.54M | 288.21M | -153.69M | -52.31M | 60.95M |
| Income Tax Expenses | -5.05M | 12.71M | -404.00K | 2.08M | 4.64M |
| Earnings from Continuing Operations | -228.49M | 275.51M | -153.29M | -54.39M | 56.31M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 130.00K | -235.00K | -262.00K | -208.00K | -105.00K |
| Net Income | -228.36M | 275.27M | -153.55M | -54.60M | 56.21M |
| EBIT | -230.48M | 297.12M | -147.73M | -48.37M | 67.81M |
| EBITDA | -223.51M | 303.85M | -138.50M | -40.87M | 75.41M |
| EPS Basic | -0.89 | 1.10 | -0.62 | -0.22 | 0.24 |
| Normalized Basic EPS | -0.57 | 0.72 | -0.39 | -0.14 | 0.16 |
| EPS Diluted | -0.89 | 0.92 | -0.68 | -0.22 | 0.20 |
| Normalized Diluted EPS | -0.57 | 0.59 | -0.39 | -0.14 | 0.13 |
| Average Basic Shares Outstanding | 255.53M | 251.28M | 248.21M | 243.11M | 238.67M |
| Average Diluted Shares Outstanding | 255.53M | 305.94M | 248.21M | 243.11M | 303.97M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |